Daniel Pichl News Today

SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Wedbush in a report released on Thursday, RTT News reports. They presently have a $75.00 price objective on the stock, up from their previous price objective of $70.00. Wedbush’s price target indicates a potential upside of 66.26% from […]

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) saw unusually-high trading volume on Thursday . Approximately 759,786 shares traded hands during mid-day trading, a decline of 30% from the previous session’s volume of 1,085,049 shares.The stock last traded at $42.19 and had previously closed at $46.84. Analyst Ratings Changes A number of equities research analysts […]

SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) is set to release its earnings data before the market opens on Thursday, May 2nd. Analysts expect SpringWorks Therapeutics to post earnings of ($1.19) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. SpringWorks Therapeutics (NASDAQ:SWTX […]

Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) have earned an average recommendation of “Buy” from the six ratings firms that are covering the company, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the stock in […]

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Free Report) – Analysts at Wedbush raised their Q1 2024 EPS estimates for SpringWorks Therapeutics in a research report issued to clients and investors on Tuesday, February 27th. Wedbush analyst D. Nierengarten now anticipates that the company will post earnings of ($1.27) per share for the quarter, up from their […]

SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($1.44) EPS for the quarter, missing the consensus estimate of ($1.24) by ($0.20), Briefing.com reports. The company had revenue of $5.45 million during the quarter, compared to the consensus estimate of $1.26 million. During the same period in […]

SpringWorks Therapeutics (NASDAQ:SWTX – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($1.44) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.24) by ($0.20), Briefing.com reports. During the same quarter last year, the company posted ($1.19) earnings per share. SpringWorks Therapeutics Trading Up 7.4 % SWTX traded […]

Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX – Get Free Report) were down 7.3% during trading on Tuesday following insider selling activity. The stock traded as low as $48.23 and last traded at $48.55. Approximately 860,611 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 1,257,188 shares. The stock […]

Daniel Pichl, Chief People Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), executed a sale of 26,181 shares in the company on February 2, 2024, according to a recent SEC Filing.

HC Wainwright reissued their buy rating on shares of SpringWorks Therapeutics (NASDAQ:SWTX – Get Rating) in a research note issued to investors on Thursday morning, Benzinga reports. HC Wainwright currently has a $105.00 target price on the stock. Several other equities research analysts have also recently commented on the company. JPMorgan Chase & Co. upped […]